We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv... MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 6.25 | 1.12 | 1.2 | 1.03 | 429321 | 1.16091741 | CS |
4 | -0.08 | -6.29921259843 | 1.27 | 1.49 | 0.97 | 526052 | 1.1782962 | CS |
12 | 0.02 | 1.7094017094 | 1.17 | 2.5591 | 0.97 | 1483314 | 1.64342049 | CS |
26 | 0.54 | 83.0769230769 | 0.65 | 5.01 | 0.51 | 3555823 | 3.03912238 | CS |
52 | 0.13 | 12.2641509434 | 1.06 | 5.01 | 0.51 | 2010145 | 2.86969379 | CS |
156 | -5.81 | -83 | 7 | 7.9799 | 0.51 | 1473376 | 2.89899748 | CS |
260 | -5.81 | -83 | 7 | 7.9799 | 0.51 | 1473376 | 2.89899748 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions